// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Vitamin K Antagonist (VKA) Monitoring Using Point of Care Testing (POCT) in Patients with Antiphospholipid Syndrome (APS)

M. Masucci - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Antiphospholipid syndrome

N/A

Von Willebrand’s Disease: A Diagnostic Evaluation Using Current Guidelines

E. Bar - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Atrial tachyarrhythmia ablation in lateral tunnel fontan patients: a case series

V Sawhney - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Smartphone apps for the detection of AF

N Karim - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Early experience of intra-operative use of ECGI during VT ablation

A.J. Graham - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Radiofrequency balloon catheter ablation for paroxysmal atrial fibrillation, RADIANCE STUDY–a UK experience

S Honarbakhsh - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

Adenosine

Catheter ablation for atrial fibrillation on uninterrupted NOACs: a safe approach?

V Sawhney - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

Warfarin

Patients on novel oral anticoagulants require higher doses of unfractionated heparin than those on warfarin to achieve a target act value during ablation of left atrial tachyarrhythmias

D Lee - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Heparin

Modification in head up tilt test protocol increases diagnostic yield and better-elucidates the mechanism of situational syncope

CW Lim - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillation: impact of the etiology of cardiomyopathy

A. Zegard - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Screen, EAARN, or valid-CRT score, which one best predicts CRT response and long-term survival?

Rui Providencia - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Generation of the first functional map of left atrial ganglionated plexus sites that induce AV nodal bradycardia

MY Kim - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

How multinational community pharmacists worked with AF Association and Arrhythmia Alliance pulse rhythm check campaign Know Your Pulse) to raise awareness of and identify people at risk of AF

T C A Lobban - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Impact of open audit on procedural performance in electrophysiology catheter laboratory

V Sawhney - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The changing trends in new ICD and CRT-D implants over the last 20 years at a single large tertiary cardiology centre

Z Vali - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Cardiac arrest in the absence of an acute coronary artery occlusion: characteristics and outcomes of patients with primary arrhythmic arrest in a UK tertiary centre

A Anilkumar - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

HF-RADD - heart failure risk according to device diagnostics: a prospective observational study

EM Johnstone - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Day- case implant of complex pacing devices is safe and preferred by patients

P A Chousou - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Is cardiac resynchronisation therapy more effective in females than males? A comparison of STH patients and the findings of MADIT-CRT

A Cresswell - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Left atrial appendage occlusion in patients meeting the “commissioning through evaluation” eligibility criteria: high all-cause mortality seen in spite of successful device implant

A Masoud - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

Aspirin

Copyright © 2026. QuantiNova All rights reserved